Tumor (glioblastoma, with blood vessels)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22b1/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22b1/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22b0/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22b0/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22af/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22af/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22ae/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22ae/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22ad/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22ad/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22ac/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22ac/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22ab/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22ab/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22aa/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22aa/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22a9/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22a9/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22a8/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22a8/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c48a2d620471e15005f22a7/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c48a2d620471e15005f22a7/5c48a2ae20471e15005f22a5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/609551358bd6af00287e4a1e/5c48a2ae20471e15005f22a5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/609551358bd6af00287e4a1e/5c48a2ae20471e15005f22a5.png"}]